Regulus Therapeutics gains on completion of enrollment in study of RGLS4326 for kidney disease
February 10 2021 - 8:37AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Regulus Therapeutics (NASDAQ:RGLS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Regulus Therapeutics (NASDAQ:RGLS)
Historical Stock Chart
From Apr 2023 to Apr 2024